These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25085655)

  • 1. Lethal synergy involving bicyclomycin: an approach for reviving old antibiotics.
    Malik M; Li L; Zhao X; Kerns RJ; Berger JM; Drlica K
    J Antimicrob Chemother; 2014 Dec; 69(12):3227-35. PubMed ID: 25085655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens.
    Wang W; Zhu X; Luo H; Wang Z; Hong A; Zeng J; Li L; Wang D; Deng X; Zhao X
    Microbiol Spectr; 2023 Feb; 11(1):e0379022. PubMed ID: 36533939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for the mode of action of bicyclomycin.
    Kohn H; Widger W
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
    Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
    J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
    Wei WJ; Yang HF
    Int J Antimicrob Agents; 2017 Mar; 49(3):321-326. PubMed ID: 28167347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
    Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
    Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves.
    Flamm RK; Rhomberg PR; Lindley JM; Sweeney K; Ellis-Grosse EJ; Shortridge D
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
    Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
    Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics.
    Baker KR; Jana B; Hansen AM; Nielsen HM; Franzyk H; Guardabassi L
    Front Cell Infect Microbiol; 2019; 9():236. PubMed ID: 31334131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho.
    Magyar A; Zhang X; Kohn H; Widger WR
    J Biol Chem; 1996 Oct; 271(41):25369-74. PubMed ID: 8810302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 12. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
    Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
    J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
    Abdul Rahim N; Cheah SE; Johnson MD; Yu H; Sidjabat HE; Boyce J; Butler MS; Cooper MA; Fu J; Paterson DL; Nation RL; Bergen PJ; Velkov T; Li J
    J Antimicrob Chemother; 2015 Sep; 70(9):2589-97. PubMed ID: 26023209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E; Kolek B; Bonner DP; Valera L; Minassian B; Fung-Tomc J
    Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.
    Titecat M; Liang X; Lee CJ; Charlet A; Hocquet D; Lambert T; Pagès JM; Courcol R; Sebbane F; Toone EJ; Zhou P; Lemaitre N
    J Antimicrob Chemother; 2016 Oct; 71(10):2874-82. PubMed ID: 27330072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates.
    Rodríguez CH; Nastro M; Vay C; Famiglietti A
    J Med Microbiol; 2015 Oct; 64(10):1196-1200. PubMed ID: 26238719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
    Zwiefka A; Kohn H; Widger WR
    Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicyclomycin generates ROS and blocks cell division in Escherichia coli.
    Prakash A; Dutta D
    PLoS One; 2024; 19(3):e0293858. PubMed ID: 38551933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.